Evidence map›Paper›PMID 41166395›Full record

ArticleJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2026

An insight into real-world practice: What information sources inform the prescribing for children with cancer in Scotland? A focus on emesis, tumour lysis syndrome (TLS), and

Rahaf Alkhlaifat, Natalie M Weir, Tanja Mueller

Abstract read
In one paragraph

Article in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rahaf AlkhlaifatStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.ORCID 0000-0002-7007-3534
Natalie M WeirStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.ORCID 0000-0003-1422-9415
Tanja MuellerStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.ORCID 0000-0002-0418-4789

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Within clinical practice, information sources such as clinical guidelines ensure practitioners apply evidence-based information, supporting both effectiveness and safety of the prescribed medicines. Paediatric cancer - a leading cause of death in children - is a complex condition, thus is an area where clinical guidelines are important to give guidance on, e.g., recommended doses, drug dispensing, and toxicity monitoring measures. However, exploring clinical guidelines/information sources and their content regarding medicine-pertaining aspects is rarely done despite the fact they directly inform patient care. This comment summarises the main findings of a document analysis study aimed to describe available documents and their content for Scotland-based paediatric prescribers in oncology wards and provides insights into the documents' comprehensiveness and consistency. The analysis covered three clinical indications which are either highly prevalent or troublesome in practice: emesis, tumour lysis syndrome (TLS), and Pneumocystis Pneumonia (PCP) prophylaxis.

Indexed as

Antineoplastic AgentsNeoplasmsPneumonia, PneumocystisPractice Patterns, Physicians'Tumor Lysis SyndromeVomitingChildHumansInformation SourcesPractice Guidelines as TopicScotlandAntineoplastic Agentschildrenguidelinesinformationmedicinesprescribing

Identifiers

PMID41166395
PMCPMC13096612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.